Omitting completion axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases undergoing mastectomy: results from the prospective SENOMIC trial
Event-free survival after omission of cALND in breast cancer patients with SLN micrometastases undergoing mastectomy was excellent, despite a higher ARR than previously reported. Long-term follow-up is important to validate the safety of this approach, but omission of cALND should be regarded as routine care.
Authors
- Yvette Andersson (ORCID: https://orcid.org/0000-0003-0347-2196)
- Fuat Celebioglu (ORCID: https://orcid.org/0000-0002-3424-2468)
- Lisa Rydén (ORCID: https://orcid.org/0000-0001-7515-3130)
- Rebecka R. Malterling
- Anna-Karin Falck
- Jan Frisell
- Jana de Boniface (ORCID: https://orcid.org/0000-0001-9518-0902)
- Leif Bergkvist (ORCID: https://orcid.org/0000-0002-8054-8847)
- Sophie Norenstedt
- Eva Vikhe Patil
Institutions
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
- Saint Göran Hospital (SE)
- Västmanlands sjukhus Västerås (SE)
- Skåne University Hospital (SE)
- Ryhov Hospital Jönköping (SE)
- Linköping University Hospital (SE)
- Mälardalen University (SE)
Publication Details
- Journal
- British journal of surgery
- Published
- 2025-05-31
- DOI
- https://doi.org/10.1093/bjs/znaf111
- Citations
- 4
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 3.75
Funders
- Percy Falk Foundation